<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diabetes Care</journal-id>
      <journal-id journal-id-type="hwp">diacare</journal-id>
      <journal-id journal-id-type="pmc">dcare</journal-id>
      <journal-id journal-id-type="publisher-id">Diabetes Care</journal-id>
      <journal-title-group>
        <journal-title>Diabetes Care</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0149-5992</issn>
      <issn pub-type="epub">1935-5548</issn>
      <publisher>
        <publisher-name>American Diabetes Association</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19918005</article-id>
      <article-id pub-id-type="pmc">2809286</article-id>
      <article-id pub-id-type="publisher-id">1374</article-id>
      <article-id pub-id-type="doi">10.2337/dc09-1374</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
          <subj-group>
            <subject>Pathophysiology/Complications</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion</article-title>
        <subtitle>A case report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dirksen</surname>
            <given-names>Carsten</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hansen</surname>
            <given-names>Dorte L.</given-names>
          </name>
          <degrees>MD, PHD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Madsbad</surname>
            <given-names>Sten</given-names>
          </name>
          <degrees>DMSC</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hvolris</surname>
            <given-names>Lisbeth E.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Naver</surname>
            <given-names>Lars S.</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holst</surname>
            <given-names>Jens J.</given-names>
          </name>
          <degrees>DMSC</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Worm</surname>
            <given-names>Dorte</given-names>
          </name>
          <degrees>MD, PHD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1"><sup>1</sup>Department of Endocrinology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark; </aff>
        <aff id="aff2"><sup>2</sup>Department of Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark; </aff>
        <aff id="aff3"><sup>3</sup>Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Corresponding author: Carsten Dirksen, <email>cardir@gmail.com</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>11</month>
        <year>2009</year>
      </pub-date>
      <volume>33</volume>
      <issue>2</issue>
      <fpage>375</fpage>
      <lpage>377</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>7</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>11</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 by the American Diabetes Association.</copyright-statement>
        <license license-type="creative-commons">
          <license-p>Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link> for details.</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zdc00210000375.pdf"/>
      <abstract>
        <sec>
          <title>OBJECTIVE</title>
          <p>To examine after gastric bypass the effect of peroral versus gastroduodenal feeding on glucose metabolism.</p>
        </sec>
        <sec>
          <title>RESEARCH DESIGN AND METHODS</title>
          <p>A type 2 diabetic patient was examined on 2 consecutive days 5 weeks after gastric bypass. A standard liquid meal was given on the first day into the bypassed gastric remnant and on the second day perorally. Plasma glucose, insulin, C-peptide, glucagon, incretin hormones, peptide YY, and free fatty acids were measured.</p>
        </sec>
        <sec>
          <title>RESULTS</title>
          <p>Peroral feeding reduced 2-h postprandial plasma glucose (7.8 vs. 11.1 mmol/l) and incremental area under the glucose curve (iAUC) (0.33 vs. 0.49 mmol &#xB7; l<sup>&#x2212;1</sup> &#xB7; min<sup>&#x2212;1</sup>) compared with gastroduodenal feeding. &#x3B2;-Cell function (iAUC<sub>Cpeptide/Glu</sub>) was more than twofold improved during peroral feeding, and the glucagon-like peptide (GLP)-1 response increased nearly fivefold.</p>
        </sec>
        <sec>
          <title>CONCLUSIONS</title>
          <p>Improvement in postprandial glucose metabolism after gastric bypass is an immediate and direct consequence of the gastrointestinal rearrangement, associated with exaggerated GLP-1 release and independent of changes in insulin sensitivity, weight loss, and caloric restriction.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Resolution of type 2 diabetes after Roux-en-Y gastric bypass (RYGB) has been observed in several studies and involves mechanisms associated with the surgical rearrangement of the gastrointestinal tract in addition to the effect of weight loss (<xref ref-type="bibr" rid="B1">1</xref>). The mechanisms have not been established, but changed gut hormone levels after surgery may play a role (<xref ref-type="bibr" rid="B2">2</xref>).</p>
    <p>Recently, we had the unique opportunity to examine the effects of feeding either perorally (and thereby bypassing the stomach, duodenum, and proximal jejunum) or through a gastric tube inserted into the bypassed gastric remnant on the glucose metabolism in a single patient.</p>
    <sec>
      <title>RESEARCH DESIGN AND METHODS</title>
      <p>A 51-year-old male patient with type 2 diabetes (BMI 50.2 kg/m<sup>2</sup>, A1C 8.0%) treated with metformin, sulfonylurea, and insulin underwent a laparoscopic RYGB for morbid obesity.</p>
      <p>On the second postoperative day, a leakage from the gastro-jejunostomy was suspected because of fever and abdominal pain. Acute reoperation showed no firm signs of leakage, but nevertheless a percutaneous gastric tube was inserted into the bypassed gastric remnant. The tube served as the only route of nutrition during the following 3 weeks, after which the patient again was allowed peroral feeding through the gastric pouch according to a standard nutrition protocol (1,200 kcal/day). Treatment with insulin and metformin was temporarily required after the reoperation but could be discontinued 3 weeks postoperatively.</p>
      <p>We examined the patient 5 weeks postoperatively, at which time the patient was fed perorally but still had the gastric tube. The patient had lost 14 kg (BMI 45.2 kg/m<sup>2</sup>). Informed consent was obtained prior to examination.</p>
      <p>On 2 consecutive days at 8.30 <sc>a.m.</sc> after an overnight fast (8 h), a standard 200-ml liquid meal (Nutridrink; Nutricia) containing 300 kcal, with 16% protein, 49% carbohydrate, and 36% fat, was given over a period of 10 min, on the first day through the gastric tube and on the second day perorally. Blood samples were drawn from an antecubital vein at 15- to 30-min intervals (<xref ref-type="fig" rid="F1">Fig. 1</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Plasma concentrations of glucose (<italic>A</italic>), insulin (<italic>B</italic>), C-peptide (<italic>C</italic>), glucagon (<italic>D</italic>), GLP-1 (<italic>E</italic>), intact GIP (<italic>F</italic>), PYY (<italic>G</italic>), and FFAs (<italic>H</italic>) after peroral or gastroduodenal feeding in a RYGB-operated patient. Figure includes iAUC estimations. Triangles and dotted lines, peroral feeding; circles and solid lines, gastroduodenal feeding.</p>
        </caption>
        <graphic xlink:href="zdc0021080630001"/>
      </fig>
      <sec>
        <title>Laboratory analyses</title>
        <p>Plasma glucose was measured by a glucose oxidase method (ABL800Flex; Radiometer, Br&#x2298;nsh&#x2298;j, Denmark), peptide YY<sub>3&#x2013;36</sub> (PYY) with a radioimmunoassay kit (Linco Research), and free fatty acids (FFAs) by an enzymatic colorimetric method (Wako, D&#xFC;sseldorf, Germany). Plasma insulin, C-peptide, glucagon, and incretin hormone were quantified as earlier described (<xref ref-type="bibr" rid="B3">3</xref>).</p>
      </sec>
      <sec>
        <title>Calculations</title>
        <p>Incremental area under the curve (iAUC) was calculated using the trapezoidal model. &#x3B2;-Cell function was evaluated by iAUC<sub>insulin</sub>, iAUC<sub>Cpeptide</sub>, and insulinogenic index (IGI) and calculated as (insulin<sub>30</sub> &#x2212; insulin<sub>fasting</sub>)/(Glu<sub>30</sub> &#x2212; Glu<sub>fasting</sub>) and iAUC<sub>Cpeptide/Glu</sub> ratio. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as (insulin<sub>fasting</sub> &#xD7; Glu<sub>fasting</sub>)/22.5.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>RESULTS</title>
      <p>Plasma concentrations and iAUC for glucose, insulin, C-peptide, glucagon, total glucagon-like peptide-1 (GLP-1), intact glucose-dependent insulinotropic polypeptide (GIP), PYY, and FFAs after peroral and gastroduodenal feeding are shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>.</p>
      <p>Plasma glucose concentration peaked earlier and returned more rapidly to fasting values after peroral than gastroduodenal feeding, as illustrated by a markedly reduced 2-h plasma glucose concentration (7.8 vs. 11.1 mmol/l). iAUC<sub>Glu</sub> was noticeably lower after peroral feeding. The peak values of plasma insulin and C-peptide were higher after peroral than gastroduodenal feeding (fourfold and twofold, respectively) and iAUC<sub>insulin</sub> and iAUC<sub>Cpeptide</sub> were also clearly elevated. IGI was improved after peroral feeding (115 vs. 72 pmol/mmol), and the iAUC<sub>Cpeptide/Glu</sub> ratio was more than twofold increased (0.90 vs. 0.40 nmol/mmol). HOMA-IR remained unchanged on the 2 examination days (3.3 vs. 3.5).</p>
      <p>GLP-1 plasma concentration peaked simultaneously after peroral and gastroduodenal feeding, but the peak value was more than threefold increased (87 vs. 28 pmol/l), and iAUC<sub>GLP-1</sub> was nearly fivefold increased after peroral feeding. Insulin and GLP-1 correlated strongly after peroral (<italic>r</italic> = 0.92, <italic>P</italic> &lt; 0.001) but not gastroduodenal (<italic>r</italic> = 0.55, <italic>P</italic> = 0.08) feeding. Plasma concentrations of glucagon and intact GIP were similar on both days. Responses of PYY and FFAs are depicted in the figure.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSIONS</title>
      <p>Rapid improvement in glucose tolerance after RYGB surgery is a clinical reality (<xref ref-type="bibr" rid="B2">2</xref>). Here, we report important differences in &#x3B2;-cell function and glucose metabolism after peroral compared with gastroduodenal feeding in a patient with RYGB and a gastrostomy, where differences in insulin sensitivity, weight loss, and caloric restriction can be ruled out as explanations for the improved glucose tolerance.</p>
      <p>Our results show marked improvement in glucose tolerance with near normalization of 2-h postprandial plasma glucose value and a 33% reduction in iAUC<sub>Glu</sub> after peroral feeding compared with gastroduodenal feeding. In contrast, during gastroduodenal feeding glucose tolerance was diabetic with a 2-h postprandial plasma glucose value &#x223C;11 mmol/l. The improvement was accompanied by a twofold increase in &#x3B2;-cell secretory response (AUC<sub>Cpeptide/Glu</sub>), which was associated with a fivefold increase in iAUC<sub>GLP-1</sub>. Insulin and GLP-1 concentrations during peroral feeding were strongly correlated, which is suggestive of a causal relationship. Interestingly, the insulin and C-peptide response curves found after gastroduodenal feeding resemble the responses found in type 2 diabetic patients, whereas the response curves after peroral feeding are similar to those found in healthy control subjects (<xref ref-type="bibr" rid="B4">4</xref>). The emptying time is likely to be slower after feeding into the bypassed gastric remnant, which could explain the slower peak in plasma glucose observed after gastroduodenal feeding but would also, per se, be expected to result in decreased postprandial glucose excursions.</p>
      <p>The observed improvements in glucose tolerance and GLP-1 secretion are in concordance with earlier findings from patients examined before and after RYGB surgery (<xref ref-type="bibr" rid="B5">5</xref><xref ref-type="bibr" rid="B6"/><xref ref-type="bibr" rid="B7"/><xref ref-type="bibr" rid="B8"/><xref ref-type="bibr" rid="B9"/><xref ref-type="bibr" rid="B10"/><xref ref-type="bibr" rid="B11"/><xref ref-type="bibr" rid="B12"/>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>). Regarding GIP, some studies have demonstrated increased (<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B10">10</xref>) and others decreased (<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>) responses after RYGB. In our patient, GIP responses were similar on the 2 days, suggesting that changes in GIP were not responsible for the differences in insulin secretion and glucose tolerance. Also glucagon responses were similar.</p>
      <p>In conclusion, our results suggest that RYGB has a direct beneficial effect on postprandial glucose metabolism, most likely due to an increased insulin secretion caused by the massive increase in GLP-1 that is probably due to the rapid exposure of <sc>l</sc>-cells in the distal small intestine to nutrients (<xref ref-type="bibr" rid="B14">14</xref>). It has been suggested that duodenal exclusion inherent in the RYGB somehow might be responsible for the improvement in glucose tolerance (<xref ref-type="bibr" rid="B15">15</xref>). In this respect, it is of interest that the secretion of the upper jejunal hormone, GIP, was similar during peroral or gastroduodenal feeding.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p>The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked &#x201C;advertisement&#x201D; in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>No potential conflicts of interest relevant to this article were reported.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchwald</surname><given-names>H</given-names></name><name><surname>Avidor</surname><given-names>Y</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Jensen</surname><given-names>MD</given-names></name><name><surname>Pories</surname><given-names>W</given-names></name><name><surname>Fahrbach</surname><given-names>K</given-names></name><name><surname>Schoelles</surname><given-names>K</given-names></name></person-group> 
<article-title>Bariatric surgery: a systematic review and meta-analysis</article-title>. 
<source>JAMA</source><year>2004</year>;
<volume>292</volume>:
<fpage>1724</fpage>&#x2013;
<lpage>1737</lpage><pub-id pub-id-type="pmid">15479938</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname><given-names>M</given-names></name><name><surname>Oliv&#xE1;n</surname><given-names>B</given-names></name><name><surname>Teixeira</surname><given-names>J</given-names></name><name><surname>Pi-Sunyer</surname><given-names>FX</given-names></name><name><surname>Laferr&#xE8;re</surname><given-names>B</given-names></name></person-group> 
<article-title>Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence?</article-title><source>Obes Surg</source><year>2009</year>;
<volume>19</volume>:
<fpage>217</fpage>&#x2013;
<lpage>229</lpage><pub-id pub-id-type="pmid">18820978</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#xF8;jberg</surname><given-names>PV</given-names></name><name><surname>Vilsb&#xF8;ll</surname><given-names>T</given-names></name><name><surname>Rab&#xF8;l</surname><given-names>R</given-names></name><name><surname>Knop</surname><given-names>FK</given-names></name><name><surname>Bache</surname><given-names>M</given-names></name><name><surname>Krarup</surname><given-names>T</given-names></name><name><surname>Holst</surname><given-names>JJ</given-names></name><name><surname>Madsbad</surname><given-names>S</given-names></name></person-group> 
<article-title>Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes</article-title>. 
<source>Diabetologia</source><year>2009</year>;
<volume>52</volume>:
<fpage>199</fpage>&#x2013;
<lpage>207</lpage><pub-id pub-id-type="pmid">19037628</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>St&#xF6;ckmann</surname><given-names>F</given-names></name><name><surname>Ebert</surname><given-names>R</given-names></name><name><surname>Creutzfeldt</surname><given-names>W</given-names></name></person-group> 
<article-title>Reduced incretin effect in type 2 (non-insulin-dependent) diabetes</article-title>. 
<source>Diabetologia</source><year>1986</year>;
<volume>29</volume>:
<fpage>46</fpage>&#x2013;
<lpage>52</lpage><pub-id pub-id-type="pmid">3514343</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>CM</given-names></name><name><surname>le Roux</surname><given-names>CW</given-names></name><name><surname>Ghatei</surname><given-names>MA</given-names></name><name><surname>Bloom</surname><given-names>SR</given-names></name><name><surname>Patel</surname><given-names>AG</given-names></name><name><surname>Aylwin</surname><given-names>SJ</given-names></name></person-group> 
<article-title>Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety</article-title>. 
<source>Br J Surg</source><year>2006</year>;
<volume>93</volume>:
<fpage>210</fpage>&#x2013;
<lpage>215</lpage><pub-id pub-id-type="pmid">16392104</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Carvalho</surname><given-names>CP</given-names></name><name><surname>Marin</surname><given-names>DM</given-names></name><name><surname>de Souza</surname><given-names>AL</given-names></name><name><surname>Pareja</surname><given-names>JC</given-names></name><name><surname>Chaim</surname><given-names>EA</given-names></name><name><surname>de Barros Mazon</surname><given-names>S</given-names></name><name><surname>da Silva</surname><given-names>CA</given-names></name><name><surname>Geloneze</surname><given-names>B</given-names></name><name><surname>Muscelli</surname><given-names>E</given-names></name><name><surname>Alegre</surname><given-names>SM</given-names></name></person-group> 
<article-title>GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism</article-title>. 
<source>Obes Surg</source><year>2009</year>;
<volume>19</volume>:
<fpage>313</fpage>&#x2013;
<lpage>320</lpage><pub-id pub-id-type="pmid">18815849</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldfine</surname><given-names>AB</given-names></name><name><surname>Mun</surname><given-names>EC</given-names></name><name><surname>Devine</surname><given-names>E</given-names></name><name><surname>Bernier</surname><given-names>R</given-names></name><name><surname>Baz-Hecht</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>DB</given-names></name><name><surname>Schneider</surname><given-names>BE</given-names></name><name><surname>Holst</surname><given-names>JJ</given-names></name><name><surname>Patti</surname><given-names>ME</given-names></name></person-group> 
<article-title>Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal</article-title>. 
<source>J Clin Endocrinol Metab</source><year>2007</year>;
<volume>92</volume>:
<fpage>4678</fpage>&#x2013;
<lpage>4685</lpage><pub-id pub-id-type="pmid">17895322</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holdstock</surname><given-names>C</given-names></name><name><surname>Zethelius</surname><given-names>B</given-names></name><name><surname>Sundbom</surname><given-names>M</given-names></name><name><surname>Karlsson</surname><given-names>FA</given-names></name><name><surname>Ed&#xE9;n Engstr&#xF6;m</surname><given-names>B</given-names></name></person-group> 
<article-title>Postprandial changes in gut regulatory peptides in gastric bypass patients</article-title>. 
<source>Int J Obes (Lond)</source><year>2008</year>;
<volume>32</volume>:
<fpage>1640</fpage>&#x2013;
<lpage>1646</lpage><pub-id pub-id-type="pmid">18794895</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korner</surname><given-names>J</given-names></name><name><surname>Bessler</surname><given-names>M</given-names></name><name><surname>Inabnet</surname><given-names>W</given-names></name><name><surname>Taveras</surname><given-names>C</given-names></name><name><surname>Holst</surname><given-names>JJ</given-names></name></person-group> 
<article-title>Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding</article-title>. 
<source>Surg Obes Relat Dis</source><year>2007</year>;
<volume>3</volume>:
<fpage>597</fpage>&#x2013;
<lpage>601</lpage><pub-id pub-id-type="pmid">17936091</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laferr&#xE8;re</surname><given-names>B</given-names></name><name><surname>Teixeira</surname><given-names>J</given-names></name><name><surname>McGinty</surname><given-names>J</given-names></name><name><surname>Tran</surname><given-names>H</given-names></name><name><surname>Egger</surname><given-names>JR</given-names></name><name><surname>Colarusso</surname><given-names>A</given-names></name><name><surname>Kovack</surname><given-names>B</given-names></name><name><surname>Bawa</surname><given-names>B</given-names></name><name><surname>Koshy</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Yapp</surname><given-names>K</given-names></name><name><surname>Olivan</surname><given-names>B</given-names></name></person-group> 
<article-title>Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes</article-title>. 
<source>J Clin Endocrinol Metab</source><year>2008</year>;
<volume>93</volume>:
<fpage>2479</fpage>&#x2013;
<lpage>2485</lpage><pub-id pub-id-type="pmid">18430778</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>le Roux</surname><given-names>CW</given-names></name><name><surname>Aylwin</surname><given-names>SJ</given-names></name><name><surname>Batterham</surname><given-names>RL</given-names></name><name><surname>Borg</surname><given-names>CM</given-names></name><name><surname>Coyle</surname><given-names>F</given-names></name><name><surname>Prasad</surname><given-names>V</given-names></name><name><surname>Shurey</surname><given-names>S</given-names></name><name><surname>Ghatei</surname><given-names>MA</given-names></name><name><surname>Patel</surname><given-names>AG</given-names></name><name><surname>Bloom</surname><given-names>SR</given-names></name></person-group> 
<article-title>Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters</article-title>. 
<source>Ann Surg</source><year>2006</year>;
<volume>243</volume>:
<fpage>108</fpage>&#x2013;
<lpage>114</lpage><pub-id pub-id-type="pmid">16371744</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mor&#xED;nigo</surname><given-names>R</given-names></name><name><surname>Moiz&#xE9;</surname><given-names>V</given-names></name><name><surname>Musri</surname><given-names>M</given-names></name><name><surname>Lacy</surname><given-names>AM</given-names></name><name><surname>Navarro</surname><given-names>S</given-names></name><name><surname>Mar&#xED;n</surname><given-names>JL</given-names></name><name><surname>Delgado</surname><given-names>S</given-names></name><name><surname>Casamitjana</surname><given-names>R</given-names></name><name><surname>Vidal</surname><given-names>J</given-names></name></person-group> 
<article-title>Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects</article-title>. 
<source>J Clin Endocrinol Metab</source><year>2006</year>;
<volume>91</volume>:
<fpage>1735</fpage>&#x2013;
<lpage>1740</lpage><pub-id pub-id-type="pmid">16478824</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodieux</surname><given-names>F</given-names></name><name><surname>Giusti</surname><given-names>V</given-names></name><name><surname>D'Alessio</surname><given-names>DA</given-names></name><name><surname>Suter</surname><given-names>M</given-names></name><name><surname>Tappy</surname><given-names>L</given-names></name></person-group> 
<article-title>Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release</article-title>. 
<source>Obesity (Silver Spring)</source><year>2008</year>;
<volume>16</volume>:
<fpage>298</fpage>&#x2013;
<lpage>305</lpage><pub-id pub-id-type="pmid">18239636</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holst</surname><given-names>JJ</given-names></name><name><surname>S&#xF8;rensen</surname><given-names>TI</given-names></name><name><surname>Andersen</surname><given-names>AN</given-names></name><name><surname>Stadil</surname><given-names>F</given-names></name><name><surname>Andersen</surname><given-names>B</given-names></name><name><surname>Lauritsen</surname><given-names>KB</given-names></name><name><surname>Klein</surname><given-names>HC</given-names></name></person-group> 
<article-title>Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio</article-title>. 
<source>Scand J Gastroenterol</source><year>1979</year>;
<volume>14</volume>:
<fpage>205</fpage>&#x2013;
<lpage>207</lpage><pub-id pub-id-type="pmid">432544</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubino</surname><given-names>F</given-names></name><name><surname>Forgione</surname><given-names>A</given-names></name><name><surname>Cummings</surname><given-names>DE</given-names></name><name><surname>Vix</surname><given-names>M</given-names></name><name><surname>Gnuli</surname><given-names>D</given-names></name><name><surname>Mingrone</surname><given-names>G</given-names></name><name><surname>Castagneto</surname><given-names>M</given-names></name><name><surname>Marescaux</surname><given-names>J</given-names></name></person-group> 
<article-title>The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes</article-title>. 
<source>Ann Surg</source><year>2006</year>;
<volume>244</volume>:
<fpage>741</fpage>&#x2013;
<lpage>749</lpage><pub-id pub-id-type="pmid">17060767</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
